Dr.Reddy's Laboratories informs about outcome of board meeting

30 Jan 2024 Evaluate
Dr.Reddy's Laboratories has informed that the Board of Directors of the Company, at its meeting held on January 30, 2024, has approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2023. In terms of the above, it also enclosed the following: Unaudited Consolidated Financial Results of the Company and its subsidiaries for the quarter and nine months ended December 31, 2023, prepared in compliance with International Financial Reporting Standards (IFRS) as issued by International Accounting Standards Board (IASB); Press Release on Financial Results of the Company for the above period; Unaudited Consolidated Financial Results of the Company and its subsidiaries for the quarter and nine months ended December 31, 2023, as per Indian Accounting Standards; Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2023, as per Indian Accounting Standards. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Limited Review Reports of the Statutory Auditors on the Unaudited Standalone and Consolidated Financial Results as mentioned at serial nos. 3 and 4 are also enclosed. The Board Meeting commenced at 11.54 am IST and concluded at 3.45 pm IST.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1218.00 23.45 (1.96%)
22-Nov-2024 14:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.50
Dr. Reddys Lab 1218.00
Cipla 1491.40
Lupin 2067.80
Zydus Lifesciences 949.35
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.